BP000307-PRO-472: Recombinant Human CD11b
Source: E.coli-derived.
Applications: ELISA, Inhibition Assays, WB.C073P: Liraglutide Biosimilar
Source: The recombinant peptide liraglutide biosimilar was produced in the liraglutide stable cell line.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by liraglutide.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C074P: Semaglutide Biosimilar
Source: The recombinant peptide semaglutide biosimilar was produced in the semaglutide stable cell line.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C074PS: Semaglutide Synthetic Peptide
Source: The semaglutide peptide was synthesized.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.